Cerebrolysin
Nootropic- Molecular Formula
- Peptide mixture (>100 components)
- Molar Mass
- Variable (predominantly <10,000 g/mol)
- CAS Number
- 12656-61-0
- Purity Standard
- Pharmaceutical grade (GMP manufactured)
- Amino Acid Sequence
- Porcine brain-derived neuropeptide mixture including fragments of BDNF, NGF, GDNF, CNTF, and other neurotrophic factors
Overview
Cerebrolysin is a unique neuropeptide preparation consisting of standardized low-molecular-weight peptide fragments derived from porcine brain tissue through enzymatic proteolysis. The mixture contains biologically active fragments of multiple neurotrophic factors including BDNF, NGF, GDNF, and CNTF, providing a multi-target neurotrophic approach.
The low molecular weight of Cerebrolysin's components (predominantly <10 kDa) enables blood-brain barrier penetration, distinguishing it from full-length neurotrophic factors that cannot cross into the CNS. This allows parenteral administration to produce direct effects on brain tissue.
Extensive clinical research, particularly in Europe and Asia, has investigated Cerebrolysin for stroke recovery, Alzheimer's disease, traumatic brain injury, and various pediatric neurological conditions. Studies suggest it promotes neuronal survival, stimulates neuroplasticity, and enhances recovery of neurological function.
The mechanism of action is multifaceted, reflecting the mixture's diverse composition. Effects include increased expression of synaptic proteins, enhanced neurite outgrowth, protection against excitotoxicity, and modulation of inflammatory responses in damaged brain tissue. This polypharmacological profile may provide advantages over single-target approaches for complex neurological conditions.
Synthesis Overview
Cerebrolysin is produced through a proprietary standardized enzymatic degradation process applied to purified porcine brain proteins. The controlled proteolysis generates a consistent mixture of low-molecular-weight neuropeptides and free amino acids. The manufacturing process includes multiple filtration and purification steps to remove larger proteins and ensure batch-to-batch consistency. Quality control involves peptide mapping, amino acid analysis, and functional testing for neurotrophic activity.
Research Applications
- Stroke recovery and acute ischemic brain injury research
- Alzheimer's disease and vascular dementia studies
- Traumatic brain injury neuroprotection investigation
- Neurotrophic factor replacement therapy research
- Synaptic plasticity and long-term potentiation studies
- Pediatric neurological disorder intervention research
Related Compounds
C37H51N9O10S
813.93 g/mol
Semax is a synthetic heptapeptide analog of the adrenocorticotropic hormone (ACTH) fragment 4-10, developed in Russia as a nootropic and neuroprotecti...
View Full ProfileC33H57N11O9
751.88 g/mol
Selank is a synthetic heptapeptide derived from the naturally occurring immunomodulatory peptide tuftsin, with a Pro-Gly-Pro extension at the C-termin...
View Full ProfileC27H44N4O4
492.67 g/mol
Dihexa is a synthetic derivative of angiotensin IV developed at Washington State University as a cognitive-enhancing compound. Unlike its parent pepti...
View Full Profile